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Emerging contaminants have been of importance in recent water
research. Wastewater treatment plants (WWTPs) have proved ineffective at
handling present-day antibiotic loads from hospital and municipal sources.
Kolpin et al. (2002) performed a study that identified pharmaceuticals in
numerous waters downstream from effluent discharge. Though present in trace
levels, concern has been raised regarding pharmaceutical persistence in natural
environments. In the present study, uptake rates were quantified in the
laboratory for 25 pharmaceutical compounds using Polar Organic Chemical
Integrative Samplers (POCIS). Twenty new uptake rates were determined for
compounds that have no previously reported literature values. POCIS was also
used to evaluate the fate of polar organic contaminants in Nebraska surface
waters impacted by WWTP effluent. Select pharmaceuticals were observed to
persist for at least 1300 m downstream. Carbamazepine and DEET showed
persistence and the highest average concentrations of 110 and 60 ng/L,
respectively. Decay rates were determined for 25 pharmaceuticals in receiving
waters. Pharmaceutical loading rates were calculated for each compound using
the average in-stream concentration and volumetric flow rate.
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Chapter 1
Introduction
Recently there has been increased interest in the occurrence and behavior of
organic wastewater microconstituents, including pharmaceuticals, personal care
products, and steroid hormones, in waters across the country. One of the
primary sources of these compounds to natural waters is effluent from
wastewater treatment plants (WWTPs) (Glassmeyer et al. 2005; Lee and
Rasmussen 2006; Miao et al. 2004). One of the potential concerns about the
presence of these compounds is that they may be biologically active, with
negative consequences for aquatic species. There are few published studies of
the ecotoxicological impacts of chronic low-level exposures of therapeutic or illicit
pharmaceuticals in aquatic systems (Fent et al. 2006; Pounds et al. 2008),
though these chemicals may have effects at environmentally-relevant
concentrations (Raldua et al. 2008; Schreiber and Szewzyk 2008). Because
these compounds are biologically-active, both ecotoxicological and human health
impacts are of potential concern.
Although the occurrence and concentration of illicit and therapeutic
pharmaceuticals in natural waters have been documented based on discrete
sampling events, there are fewer data available regarding the time-weighted
average concentrations of these compounds in receiving waters downstream of
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WWTP outfalls. Traditional water sampling approaches, such as grab and
composite sampling, are effective for documenting the occurrence of
pharmaceuticals, but these sampling techniques only capture information at the
time of sample collection, and may miss events such as changes in the flow
regime, chemical inputs and/or the influence of precipitation (MacLeod et al.
2007). Monitoring temporal changes in pharmaceutical concentrations via
continuous on-line sampling methods may be prohibitively expensive. One
device that has been developed for use in sampling trace organic compounds is
the Polar Organic Chemical Integrative Sampler (POCIS). This sampling device
is designed to trap polar organic compounds from water. Its ease of use and
apparent resistance to biofouling make it particularly attractive for determining
time-weighted average (TWA) concentrations of organic compounds in water
(Alvarez et al. 2004). POCIS samplers have been used previously for both
qualitative and quantitative evaluation of pharmaceuticals, pesticides and
hormones in surface waters (Alvarez et al. 2004, 2007; Arditsoglou and Voutsa
2008; Harman et al. 2008; Jones-Lepp et al. 2004; MacLeod et al. 2007; Zhang
et al. 2008).
The hypothesis of this study is that passive samplers can be used to
evaluate the occurrence and behavior of pharmaceuticals in surface waters
impacted by wastewater treatment plant effluent. The objectives of this research
project were: (1) to quantify POCIS uptake rates for 25 pharmaceutical
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compounds by conducting a laboratory uptake study, (2) to deploy passive
samplers to evaluate the fate of polar organic contaminants in surface waters in
Nebraska impacted by wastewater treatment plant (WWTP) effluent, and (3) to
determine decay rates for pharmaceuticals in receiving waters.
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Chapter 2
Literature Review
Traditional sampling technologies
Accurate assessments of contaminant concentrations based on traditional
grab sampling methods are not always possible. Very large sample volumes are
required to accurately sample contaminants at low levels and there is often low
recovery of polar compounds in liquid to liquid extraction techniques.
Volatilization, adsorption to container walls, and chemical degradation are also of
concern when using grab sampling techniques. Due to the short sample
collection period along with transport and storage implications, discrete sampling
only provides information on the instantaneous concentration, in contrast to data
regarding time weighted average (TWA) concentrations provided by integrative
passive samplers (Greenwood et al. 2009).
Automated sampling methods give a better indication of average water
constituents than grab sampling. Automated samplers are designed to take
samples at specified intervals, which can provide a clearer indication of variation
in pollutant concentration over time. However, this process is also subject to
high levels of contamination via sampling tubes, valves, and pumps (Greenwood
et al. 2009). Contamination by trace level compounds plays an important part in
the integrity of the sample. Modeling and assessments drawn from sampling
studies may be potentially skewed due to excess contamination.
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Aquatic organisms have also been used to determine the biological
relevance associated with the presence of organic microcontaminants. Often,
fish have been deployed downstream from wastewater treatment plant (WWTP)
effluent to assess changes in pollutant concentration via bioaccumulation.
Variation in body tissue concentration over a given time period is comparable to
fluctuation in aqueous pollutant concentration. This approach of measuring
pollutant concentrations in water also has limitations. The aquatic organisms
cannot be exposed to environments where concentrations may exceed toxic
levels. Information on background levels of contaminant present in the organism
prior to deployment presents a problem as well as cost associated with tissue
sample recovery (Greenwood et al. 2009). Biological indicators also do not
typically specifically identify the compound present, but rather, identify the
biological effect resulting from exposure to a compound or other environmental
stressors. Passive samplers have been recommended as an approach to
circumvent potential problems associated with grab sampling, automated
sampling, and use of biological indicators.

Passive sampling technologies
Passive diffusion is a transport mechanism in which molecules move from
an area of high concentration to an area of lower concentration until equilibrium
conditions are reached. Unlike active transport, passive diffusion does not
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require any additional energy or forcing against concentration gradients, which
provides unbiased results regarding contaminant transport. Diffusion-based
passive samplers rely on this method to monitor chemical uptake. These
samplers consist of a porous hydrophilic membrane that allow for accumulation
of certain organic contaminants, while rejecting others. Fick’s first law of
diffusion describes the flow of contaminant during passive sampling.
NA = (DS/L)C

(1)

where NA is the mass flow rate, C is the analyte concentration, S and L are
surface area and diffusive length, respectively and D is the analyte diffusive
coefficient in air (Ballesta et al. 1993).
Passive samplers have been used in environmental monitoring for over 30
years. Original passive sampling technologies were developed for air monitoring
applications. Ballesta et al. (1993) developed a diffusion-based passive sampler
to detect toluene present in air. The sampler contained a Teflon base and cover,
porous membrane, stainless steel rings and locks for adsorbent media
compaction. The adsorbent used for toluene collection was pre-activated
coconut charcoal. In addition to quality toluene sampling rates near 50 cm3/min,
the sampler is reusable and adsorbent exchangeable (Ballesta et al. 1993).
The Radiello passive sampler was established by Maugeri of Italy, in order
to sample inorganic and organic pollutants. These include but are not limited to
benzene-toluene-xylenes (BTX), VOC, nitrogen dioxide (NO2), sulfur dioxide
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(SO2), ozone (O3), and other airborne pollutants (Namiesnik et al. 2005). The
sampler is named after its radial geometric shape. It has a cylindrical, diffusive
membrane with micropores and an adsorbing cartridge for compound
accumulation (Namiesnik et al. 2005).
More recently, passive samplers have been developed to monitor
pollutant concentrations in water and soil (Greenwood et al. 2009). The need for
using passive samplers for contaminant identification has been discussed in the
literature, primarily due to low levels of contamination present in environmental
media and the high analyte recovery in passive samplers at low concentrations
(Alvarez et al. 2004).
For example, the Ceramic Toximeter was designed to combine an
integrative passive sampling technique compatible with bioassay analysis for
groundwater applications (Bopp et al. 2007). Biosilon, a high surface area
polystyrene microsphere typically used as a growth support for bacteria, was
used as the sorbent media to sequester polycyclic aromatic hydrocarbons. The
results from the experiment confirmed the ability for passive samplers to remain
in the linear uptake phase for an extended period of time. The Ceramic
Toximeter displayed linear uptake through the 42-day deployment without
fouling, (i.e. membrane deterioration or hydrodynamic flow). Discrete samples
were also taken in duplicates bi-weekly for comparison to validate results from
the Ceramic Toximeter. The only limitation was the sampler’s inability to uptake
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smaller aromatic compounds compared to larger compounds over the same
period of time (Bopp et al. 2007).
The passive in-situ concentration-extraction sampler (PISCES) was
introduced in 1993 (Namiesnik et al. 2005). The sampler is comprised of a
metallic t-shaped pipe with hexane as the solvent. Once sealed, the PISCES is
suspended in a water column with the membranes facing downward for
contaminant accumulation. PISCES was successful for identifying organic
microconstituents, such as poly-chlorinated biphenyls (PCBs), and has since
been considered for field studies evaluating the occurrence of other
contaminants (Namiesnik et al. 2005).
Semi-permeable membrane devices or SPMDs, were among the first
passive sampler devices being designed. From 1990 until the present, over 200
studies have been completed using SPMDs for environmental monitoring (Vrana
et al. 2005). SPMDs are comprised of a flat laying, low-density polyethylene
(LDPE) tubing filled with a high-molecular weight lipid (Namiesnik et al.2005;
Vrana et al. 2005). Synthetic triolein (Glycerine trioleate) is often the filling of
choice. LDPE is a non-porous material, so it is selective and only allows fully
dissolved and unbound molecules to diffuse through the membrane (Vrana et al.
2005). Along with the ease of use, their ability to quantify pollutant-aqueous
phase concentrations, their flexible field deployment periods and their ability to
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determine TWA concentrations, SPMDs are one the most effective passive
sampling technologies available (Namiesnik et al. 2005; Zhang et al. 2008).
Solid-phase microextraction (SPME) is a passive sampling method, which
does not require the use of any solvent. This method is accomplished in two
distinct ways: Direct, where the extraction fiber of SPME is immersed in media
and Indirect, where the extraction fiber of SPME is placed in the headspace layer
at equilibrium with media. The SPME fiber extracts analytes without collecting a
sample. This is accomplished by compound sorption onto the thin film of a
stationary phase coated on SPME fibers (Namiesnik et al. 2005). One drawback
to this technique is that SPME cannot be used for long-term monitoring. SPME
data obtained over longer periods of time was only comparable to grab sample
quality, which excludes changes over time (Namiesnik et al. 2005).

Polar Organic Integrative Samplers (POCIS)
Polar Organic Chemical Integrative Samplers (POCIS) were designed by
scientists at United States Geological Survey (USGS) to sequester hydrophilic
compounds from water. The POCIS is comprised of a solid sequestration media
inside a polyethersulfone (PES) membrane, which is held together by stainless
steel compression rings (Figure 1).
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Figure 1. POCIS and Deployment Canister

The stainless steel screws securing the rings are passively resistant to oxidation
allowing optimal performance in water. Two designs of POCIS media exist for
distinct target analytes. A copolymer, Oasis HLB (polydivinylbenzene-co-Nvinylpyrrolidone) is the sorbent media aimed at pharmaceuticals, while Triphasic

admixture is designed for pesticides (Alvarez et al. 2004). The sampler has three
components: the water boundary layer, the diffusive membrane, and the
receiving phase (Greenwood et al. 2009). The water boundary layer comprises
the zone of aqueous solution immediately adjacent to the bulk water
environment. The diffusive membrane allows specific contaminants from the
water boundary layer to reach the receiving phase. The diffusive membrane is
derived of PES, with micropores that allow polar compounds to enter, while
rejecting particulates, colloids, and other microbes. The receiving phase,
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comprised of sorbent media, acts an infinite sink for the contaminants by
maintaining a concentration close to zero. This results in optimal mass transfer
by diffusion. The only limitation for mass transfer is the actual surface area
available for contaminant transfer (Greenwood et al. 2009).
The process of compound accumulation on the sorbent media is a first
order reaction (Alvarez et al. 2004). First-order kinetic models include an
integrative phase, curvilinear phase, and equilibrium partitioning phase. During
the integrative phase, the sampler acts as an infinite sink for contaminants with
log-linear uptake, as shown in Figure 2. (Alvarez et al. 2004).

Figure 2. Time series concentration change illustrating
First Order (log linear) uptake rate
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In order to use the POCIS quantitatively, an uptake rate (Rs) must be
determined experimentally for the compounds of interest (Alvarez et al. 2004).
The uptake rate can be determined as:
RS = (Dw/Lw)A

(2)

where the uptake rate Rs is in units of (L/d), Dw is the compound-specific
aqueous diffusive coefficient (m2/s), Lw is the aqueous film layer thickness (m),
and A is the available surface area (m2). Once an uptake rate has been
calculated, the time-weighted average water concentration of the contaminant of
interest can be calculated as:
Cw = CsMs/ Rst

(3)

where Cw (ng/L) and Cs (ng/g) are the analyte concentration in water and
sorbent, respectively; Ms (g) is the mass of the sorbent, Rs (L/d) is the uptake rate
determined from equation above; and t (d) is the exposure time.
POCIS have the advantage of being able to retain contaminants from the
initial integrative phase, while still being able to acquire additional contaminants.
They have the ability to handle large volumes of water over time with the addition
of evaluating variations in contaminant concentration and flow rates (Alvarez et
al. 2004). Though the POCIS has been used in numerous studies investigating
the occurrence of organic wastewater contaminants (Alvarez et al. 2004; Jones-
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Lepp et al. 2004; MacLeod et al. 2007; Togola and Budzinski 2007), its use for
estimating concentrations have been limited. Uptake rates have to be calculated
for compounds of interest before POCIS can be used quantitatively (Soderstrom
et al. 2009). Published sampling rates are available for only a relatively small
number of pharmaceuticals (Bartelt-Hunt et al. 2009). In addition, calculated
uptake rates have been demonstrated to be sensitive to a number of
environmental factors including salinity, temperature, and pH (Togola and
Budzinski 2007; Soderstrom et al. 2009). Variability of uptake rates within a
factor of 2 to 3 is consistent with variability in contaminant concentrations
observed in the field based on continuous monitoring over an extended period
(Togola and Budzinski 2007). POCIS samplers have been used previously for
both qualitative and semi-quantitative evaluation of pharmaceuticals, pesticides
and hormones in surface waters (Alvarez et al. 2004, Jones-Lepp et al. 2004;
Alvarez et al. 2007; MacLeod et al. 2007; Arditsoglou and Voutsa 2008; Harman
et al. 2008; Zhang et al. 2008; Sellin et al. 2009).

Occurrence of Pharmaceuticals in WWTP effluents
More than 70% percent of antibiotics are excreted in their active state
(Kummerer 2009). Some antibiotic and pharmaceutical compounds are reduced
or eliminated in biological wastewater treatment plant processes, while others are
converted to their biologically active form. If not eliminated during sewage
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treatment or purification processes, these pharmaceuticals persist and can be
discharged in surface water. These de-conjugated or metabolized byproducts
have toxicity equal to or exceeding the original compound (Nikolaou et al. 2007).
Clofibric acid (C10H11ClO3) in the range of 0.80 to 2.0 μg/L was the first
reported pharmaceutical evidence in wastewater effluent by Garrison in the late
1970s (Jones-Lepp et al. 2004). Since that time, numerous studies have
investigated the occurrence of pharmaceuticals in WWTP effluents. The
occurrence of emerging contaminants was investigated by Kolpin et al. (2002)
study that examined surface waters downstream from areas of urbanization and
livestock production. Over a one-year period, samples were collected from over
100 streams in 30 separate states. Approximately half of the streams contained
at least 7 contaminants, one-third had 10 or more different compounds, and a
maximum of 38 contaminants were identified in one stream (Kolpin et al. 2002).
Steroids, nonprescription drugs, and detergent metabolites were the most
frequently detected compounds within the streams analyzed. Steroids,
nonprescription drugs, and antibiotics occurred at maximum concentrations of
18.3, 17.4 and 3.6 μg/L, respectively.
Nikolaou et al. (2007) conducted a study that compiled effluent
pharmaceutical occurrence from previously published sources. Antibiotics, antiinflammatory drugs, lipid regulators, steroids, and hormones were identified as
common pharmaceuticals discharged from hospital and municipal environments.
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German WWTP effluents and river waters were found to contain 32 different
pharmaceutical compounds in a moderate ng/L range. The Hoje River, a
Swedish river, was found to contain ibuprofen, ketoprofen, naproxen, diclofenac,
atenolol, metoprolol, propanolol, trimetoprim, sulfamethoxazole, carbamazepine,
and gemfibrozil in the range of 0.12 to 2.2 μg/L. Carbamazepine has been
detected at over 40 American rivers at an average concentration of 60 ng/L.
Sewage treatment effluent studies in the United Kingdom (UK) identified
ibuprofen in 86% of all streams surveyed at an average concentration of 3086
ng/L. Norwegian WWTP effluents displayed mean concentrations of caffeine,
triclosan, and ibuprofen of 151, 1.3 and 10 μg/L, respectively. A study of
antibiotics in New Mexico hospital effluents revealed sulfamethoxazole,
trimethoprim, ciprofloxacin, ofloxacin, lincomycin, and penicillin G. Ibuprofen and
sulfamethoxazole showed persistence in surface waters assessed in mean
concentrations of 4.2 and 0.6 μg/L, respectively (Carballa et al. 2004).
Spongberg and Witter (2008) performed a study on 3 WWTPs located in
northwestern Ohio. Influent and effluent concentrations from urban, surburban,
and rural locations were measured to analyze degradation and persistence.
Influent concentrations were identified for caffeine, carbamazepine, cotinine,
sulfadimethoxine, sulfamethazine, and sulfamethoxazole of 2.5, 0.04, 0.20,
0.003, 0.03 and 0.26, respectively. The effluent concentrations varied by specific
compound. Caffeine was readily degraded over the time period and had minimal
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residue in the effluent. Carbamazepine and sulfamethoxazole, however, both
had effluent concentrations that exceeded influent by a factor of 2. The
remaining 3 compounds failed to be detected due to limits of quantification.
Wu et al. (2009) performed a study around the agricultural area of Lake
Erie basin. A total of 18 pharmaceuticals were investigated for occurrence and
fate in aqueous and soil locations. Surface waters in the Lake Erie basin do not
receive wastewater effluent, but are susceptible to agricultural and septic tank
runoff. Yearly application of biosolids to sampling area also plays a part in
microcontaminant transport. The sampling area was separated into 3
watersheds, where caffeine was by far the most frequently detected compound
and found in the largest quantity of 4275 ng L-1. Erythromycin, lincomycin,
sulfamethazine, and sulfamethoxazole were the pharmaceuticals with veterinary
applications, and had lower detection frequencies ranging from 6 to 24 percent.
These compounds had maximum detected concentrations in ng L -1 of 438, 5, 10,
and 112, respectively. Of all sediment samples collected, no pharmaceutical
compound was present above method detection limits (MDL). Wu et al. (2009)
described the pharmaceuticals as polar and hydrophilic, favoring to aqueous
phase over partitioning into sediment.
Xu et al. (2009) published a study on agricultural soils, where wastewater
effluent is used for irrigation purposes. The following pharmaceutical and
personal care products (PPCPs): clofibric acid, ibuprofen, naproxen, triclosan,
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diclofenac, and bisphenol A were observed for degradation and adsorption
properties. These particular compounds were selected due to prevalence in
agricultural runoff studies. Degradation and adsorption were assessed as
function of 4 agricultural soil types. Handford loamy sand (HLS), Arlington sandy
loam (ASL), Imperial silty clay (ISC), and Palouse silt loam (PSL) were the soils
tested in experimental portion of study. 1st order exponential decay model and
Freundlich isotherm were used to determine degradation rate constant and
adsorption coefficient. All PPCPs in the four soils exhibited persistence. The
half lives of the compounds ranged from 0.8 to 20.4 d for bisphenol A and
diclofenac, respectively.
Due to widespread use of antibiotics for disease control and disinfection,
waters have suffered an unusual loading of contaminants. Tong et al. (2009)
discussed available methods in which to rapidly detect these contaminants that
may harm the environment. The 13 antibiotics studied are often used in
veterinary medicines that belong to sulfonamide, fluoroquinolone, tetracycline,
and chloramphenicol categories. Grab samples were collected at two pig farm
waste streams (P1 & P2) during the summer and winter in Hubei, China. Eight
distinct samples were collected from the sites, which include groundwater
summer, groundwater winter, lake water summer, lake water winter, P1 summer,
P1 winter, P2 summer, and P2 winter. Fluoroquinolone and tetracycline
concentrations were considerably higher in the winter months, which may be
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attributed to decreased microbial activity. Ciprofloxacin had the highest winter
lake water concentration spike of 12 ng L-1. Tetracycline displayed the largest
summer lake water concentration of 12 ng L-1. Groundwater samples were not
as large lake water and were in the range of 1.6 to 8.5 ng L-1. Large quantities of
antibiotics were present in P1 and P2 wastewater effluents. Sulfamerazine had
the largest P1 summer, P2 summer, and P2 winter concentrations, all exceeding
10,000 ng L-1. Ciprofloxacin had the highest treatment system elimination rate of
approximately 96%, while doxycycline had the lowest of 65%. Sulfathiazole and
chlortetracycline were barely detected in the wastewater effluents, which may be
attributed to adequate treatment removal, biodegradation, sorption, or photolysis
processes.
Kuchta et al. (2009) conducted a study, which identified lincomycin in
snowmelt runoff water after land application of liquid swine manure. Land
application of biosolids is a method that provides nutrients to soil, and reduces
the necessity of land filling or incineration. A couple of closed basins, ephemeral
wetlands, and dugouts were sampled in Saskatchewan, Canada during the
study. The amount of liquid manure applied to closed basin section of field 1
and field 2 were 88,000 and 110,000 L ha-1, respectively. Lincomycin was
present in all runoff samples acquired from each site location. There was a
mean concentration of 0.27 μg L-1 and 0.39 ug L-1 for field 1 and field 2,
respectively. Manure was not applied to wetlands, so as expected the mean
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concentration was a bit lower approximately 0.16 μg L-1. Lincomycin had a mean
concentration in the dugout portion of field 1 of 0.12 ug L-1 and field 2 was 0.21
μg L-1. Water present in the dugouts may have contributed to antibiotic dilution
and decrease in concentration.
Andreu et al. (2009) produced a study that acknowledged a superior
method for extracting compounds from soil, which was a combination of
ethylenediamine tetraacetic acid-treated sand, water at a temperature of 70oC,
followed by SPE cleanup. CTC, DC, OTC, and TC were the –tetracycline
compounds evaluated and had recovery rates from soil ranging from 71 to 96%.
Recovery rates were calculated at 1.2 and 12.5 μg L-1. Though the magnitude of
the concentrations varied, the overall trend of each distinct compound was
comparable.

Fate of Pharmaceuticals in receiving waters
There have been a limited number of studies investigating the fate of
pharmaceuticals in receiving waters. Pharmaceuticals can be removed from
environmental systems by a number of processes. These processes include but
are not limited to photolysis, sorption, biodegradation, and hydrolysis. These
elimination pathways remove some fraction of pharmaceuticals in natural
systems, but certain pharmaceuticals can likely persist in aquatic systems with
potentially adverse effects. One study determined an influent concentration for
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caffeine of 63.2 μg/L (Miao et al. 2005). Another study operated under similar
conditions found a caffeine effluent concentration of 4.5 μg/L that verified
degradation during treatment (Batt et al. 2006). Batt et al. (2006) evaluated the
persistence of additional antibiotics in receiving waters at distances of 10 m, 20
m, and 100 m from the effluent source, and found that many of these compounds
persisted for at least 100 m from the source. Pharmaceutical concentrations
observed in surface waters were lower than those measured at the WWTP
outfall, indicating that dilution and/or degradation processes must be occurring
(Batt et al. 2006).
Photolysis. Photolysis is a degradation process, which effects lightsensitive compounds and serves as a removal method of pharmaceuticals in
shallow surface waters downstream from WWTP effluent (Kummerer 2009).
Some antibiotics are sensitive to light, but not all are photodegradable.
Tetracyclines, sulfa-drugs, and tylosin have all show high photodegradation in
previous surface waster studies. Photolysis is directly related to light intensity
and frequency, so it is not a dominant mode of degradation in heavily turbid
waters (Kummerer 2009).
Few studies exist, which address pharmaceutically active compounds and
their interaction with UV light. A study conducted by Pereira et al. (2007)
determined photodecomposition of different pharmaceuticals. Carbamazepine,
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an anti-convulsant, was found to be minimally affected by light sources. After
exposure to light, less 5% of the compounds underwent degradation.
Carbamazepine and other compounds with similar structures tend to absorb light
within the lower wavelength range of 200-240 nm, so as expected degradative
properties without additives, i.e. hydrogen peroxide, barely exist (Periera et al.
2007).
Biodegradation. Biodegradation is a biological process of breaking down
organic contaminants. It is a natural occurring pathway in which contaminants
can be eliminated from water. Biodegradation affects compounds of various
structures in different ways. When compounds have low adsorptive properties,
biodegradation is the primary means of removal (Carballa et al. 2004). Many
treatment facilities utilize hydraulic retention times (HRT), which are lower than
the half-lives of common pharmaceuticals, so adequate degradation does not
occur (Kinney et al. 2006).
Loffler et al. (2005) conducted a study on biodegradation, in which an
experimental set-up with 100 ng/g of spiked pharmaceuticals, which was
analyzed for a 100-day period. Samples were taken a 0, 0.25, 1, 2, 7, 14, 28, 56
and 100 days. Quality control measures were implemented to maintain a fairly
constant pH and dissolved oxygen concentration over the specified time period.
After the 100-day period, 83 percent of the carbamazepine present in the initial
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spike was recovered. Carbamazepine displayed resistant behavior to various
biodegradation processes during soil interactions (Loffler et al. 2005; Kinney et
al. 2006).
Sorption. Sorption is a combination of adsorption and absorption
processes, and varies given the physio-chemical properties of each compound.
With particle binding, pH, and partitioning coefficients, assessing the sorption
behavior of antibiotics is difficult (Kummerer, 2009). Clofibric acid exhibited high
persistence and was negligible to sorption under normal conditions in the Loffler
study that followed the environmental persistence of microcontaminants.
Tetracylines form complexes and bond with alkaline earth metals, like calcium
and magnesium (Kummerer, 2009). Sorption to solid materials (i.e. clay, soil,
coagulants) is a key factor in the microcontaminant removal. This process does
not play a large role in the removal of contaminants with low adsorption
coefficients. The study by Carballa et al. (2004) highlighted pharmaceuticals
resistant to degradation. Ibuprofen and naproxen have low solid-liquid
partitioning coefficients, in addition to their acidic structures. Of the initial
concentrations observed carbamazepine, ibuprofen, and sulfamethoxazole had
recoveries of 67, 90, and 75 percent of initial, respectively. These
microcontaminants remained in the aqueous phase and were resistant to settling,
flocculation, and other removal processes (Carballa et al. 2004). Tolls (2001)
performed a review on the sorption of veterinary pharmaceuticals in soil. Various
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compounds were analyzed and their interaction with soil was quantified.
Sulfadiazine, fluoroquinolones, and other sulphonamides had prevalent
elimination by sorption processes to soil.
Hydrolysis. Hydrolysis is the decomposition of organic compounds when
reacted with water. The compound is separated into two or more distinct parts
with addition of a hydrogen ion. As hydrolysis occurs, compounds are broken
down into smaller compounds, which often produce degradation byproducts with
unknown toxicity (Nikolaou et al. 2007). Hydrolysis is a primary elimination
method for pesticides. The composition of the pesticide compounds allow for the
reaction with water enabling removal (EPA 1990).
Sulphanomides and quinolones are two classes of compounds, which are
resistant to hydrolysis (Kummerer, 2009). The stable structure is these organic
microcontaminants allow are resistant to the breakdown initiated by the
protonated ion. Other wastewater contaminants, like some tetracylines, have
instability and are hydrolyzed when submerged in aqueous environments.
The four removal processes: biodegradation, photolysis, sorption, and
hydrolysis all have limitations. Though not originally designed for current
municipal and hospital pharmaceutical loads, adequate WWTP removal is
necessary due to the drawbacks of each process. Biodegradation is not a factor
when a compound has high adsorptive properties, photolysis is a minimal factor
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in turbid waters, sorption is not a factor when compounds fail to form complexes
with sediment, and hydrolysis is not a factor when hydrophobic behavior persists.
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Chapter 3
Materials and Methods
POCIS samplers.
POCIS, holders and deployment canisters were obtained from
Environmental Sampling Technologies (EST Inc, St. Joseph, MO). For the field
deployment, each stainless steel canister was fitted with three pharmaceutical
POCIS filled with Oasis HLB sorbent (Waters Corporation, Milford, MA). Each
POCIS had a surface area of 41 cm2 and contained 200 mg of sorbent medium.
Laboratory Uptake Study
Uptake rates were measured in the laboratory by submerging a single POCIS
sampler in a 2L beaker of ultrapure water spiked with the pharmaceuticals of
interest (Table 1) at an initial concentration of 500 ng/L under flowing conditions.
The experiment was performed with four replicates. The water temperature was
measured to be approximately 250 C throughout the duration of the experiment.
A negative control experiment was performed in duplicate, which consisted of a
beaker containing water and POCIS, but excluded any spiked compounds to
assess the potential for contamination during the experiment. A positive control
experiment was performed, consisting of a 2L beaker containing ultrapure water
spiked with the same concentration of contaminants, but contained no POCIS.
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The purpose of the positive control was to monitor natural degradation of the
pharmaceuticals unrelated to POCIS uptake. The beakers were covered with foil
and 100 mL water samples were removed from each beaker at 0, 3, 7, 14, and
30 days. At the end of the 30-day exposure period, the POCIS was removed. All
aqueous samples and the POCIS were stored at -200C until analysis. The water
flow rate in the beakers was determined to be approximately 4.5 m/s based on
travel time around the circumference of the container.
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Table 1. Pharmaceuticals evaluated and LC-MS parameters.
Compound

Use

CAS No.

Mol.
Weight
(g/mol)

Retention
Time (min)

MRM

Collision
Energy (eV)

Cone
Voltage (V)

IDL (ng)

Non-prescription Drugs
Analgesic/
Acetaminophen

Anti-pyretic pain
reliever

103-90-2

151.16

10.73

152>110

14

30

1.58

Caffeine

Stimulant

58-08-2

194.19

11.94

195>138

18

32

0.33

1,7-dimethylxanthine

Caffeine
metabolite

611-59-6

180.16

11.25

181>124

20

32

0.61

Cotinine

Nicotine
metabolite

486-56-6

176.22

10.30

177>78

20

35

0.28

d-amphetamine

Stimulant

51-64-9

135.21

10.90

136>91

16

18

0.70

DEET

Insect repellent

134-62-3

191.27

16.70

192>119

15

25

0.66

Diphenhydramine

Anti-histamine

58-73-1

255.35

12.89

256>167

14

25

0.35

Ibuprofen

Anti-inflammatory

15687-27-1

206.28

18.51

207>161

Methamphetamine

Stimulant

537-46-2

149.23

10.99

150>91

20

20

0.43

Ractopamine

Beta agonist

90274-24-1

301.38

11.09

302>164

18

16

0.18

Anti-convulsive

298-46-4

236.27

15.66

237>194

22

32

0.71

Prescription Drugs
Carbamazepine
Veterinary and Human

34

35

Antibiotics
Azithromycin

Antibiotic

83905-01-5

748.98

12.63

750>592

25

40

2.79

Erythromycin

Antibiotic

114-07-8

733.93

14.8

734>576

32

22

0.57

Lincomycin

Antibiotic

154-21-2

406.54

10.73

407>359

38

20

0.28

Monensin

Antibiotic

17090-79-2

406.54

20.54

688>635

22

17

0.025

Sulfachloropyridazine

Antibiotic

280-32-0

284.72

12.20

285>156

15

24

0.60

57-68-1

278.33

12.03

279>156

30

18

0.19

144-82-1

270.33

11.33

271>156

24

13

0.29

310.33

13.24

311>156

20

28

0.76

270.33

11.68

271>156

13

24

0.17

12.20

254>156

15

23

0.34

Sulfamethazine
Antibiotic
Sulfamethazole
Antibiotic
Sulfadimethoxine

Antibiotic
122-11-2

Sulfamethiazole

Antibiotic
144-82-1

Sulfamethoxazole

Antibiotic

723-46-6
253.28

Sulfamerazine

Antibiotic

127-79-7

264.30

11.51

265>156

16

28

0.24

Sulfathiazole

Antibiotic

72-14-0

255.32

10.99

256>156

14

25

0.46

Thiabendazole

Anthelmintic

148-79-8

12.38

202>175

24

35

0.17
201.25

35

36

Tiamulin

Antibiotic

55297-95-5

493.74

14.56

494>192

32

24

0.44

Tylosin

Antibiotic

1401-69-0

916.10

14.44

916>772

55

32

0.041

Virginiamycin

Antibiotic

21411-53-0

525.59

16.35

526>355

16

25

0.78

phenyl-13C6 –
sulfamethazine

57-68-1

284.1

11.95

285>124

25

30

d9-methamphetamine

537-46-2

158.1

10.99

159>93

18

20

58-08-2

197.1

11.87

198>140

18

32

Internal Standards

13

C3-caffeine

36

37

Sampling Rate Calculations
Values of Rs were determined by fitting experimental uptake data to equation 3.
Data were fit for each set of sequential sampling events, and an average Rs was
calculated for the overall experiment. Some of the compounds had significant
decreases in aqueous concentration over time in the positive control experiments.
Evaporation of all solutions produced increases in concentrations for some compounds.
Dissipation data from the positive control experiments was used to correct aqueous
concentration data observed in the experimental reactors by subtracting mass losses
due to dissipation and not POCIS uptake. Varying degrees of uptake were observed for
carbamazepine, DEET, diphenylhydramine, erythromycin, ibuprofen, ractopamine,
sulfadimethoxine, sulfamerazine, thiabendazole, tylosin, azithromycin, and
sulfacholorpyridazine. Lincomycin and tiamulin experienced rapid uptake, so
experimental uptake rates could only be determined from data present between 0 and 3
days. The Rs values for these two compounds are significantly higher than others and
include no standard error because data was only obtained from one time period.
Field Deployment
Two field sites were chosen to investigate pharmaceutical fate in receiving water:
Salt Creek, downstream from the Theresa St. WWTP in Lincoln, Nebraska and the west
fork of the Big Blue River, which receives discharge from the WWTP at Hastings,
Nebraska. Additional information about the two field sites may be found in Table 2. At
each location, POCIS were placed in the effluent prior to discharge, in stream within the
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effluent mixing zone, at a location approximately 500 m downstream from the effluent
discharge, and at a location approximately 1500 m downstream from the effluent
discharge. POCIS were deployed in triplicate in a steel canister and secured in place
using a metal stake to avoid displacement of the samplers. POCIS were deployed on
May 5, 2009 and retrieved on May 28, 2009, for a 23-day exposure period. At the end
of the exposure period, POCIS were retrieved, rinsed gently with DI water, and stored at
-20˚C until analysis. Data on the ng of each compound recovered from the POCIS
samplers were converted to aqueous concentrations using the laboratory uptake rates
determined in this study.
Table 2. Wastewater Treatment Facilities sampled in Nebraska.
Facility
Location

Hastings, NE

Lincoln, NE

Receiving
Water
Body
West Fork
of the Big
Blue River

Salt Creek

Community
Population

Secondary
Treatment
Technique

Average
Daily Flow
(MGD)

25,394

Trickling
Filter

4.0

251,624

Activated
Sludge and
Trickling
Filter

18

(2008)

Determination of pharmaceutical decay rates
To determine decay rates for pharmaceuticals in receiving waters, the
experimental data was fit to the following equation:
Ct/Co= exp (-kt)

(4)
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where Ct (ng/L) is the concentration at a specific time t, Co (ng/L) is the initial
concentration at time zero, k (d-1) is the decay rate coefficient, and t (d) is duration of
time.
The sampling locations (m) were converted to a time dividing by the velocity in each
channel. Channel velocities were determined by dividing the volumetric flow rate by the
cross-sectional area of the channel. At Hastings, flow in the channel is entirely effluent,
so volumetric flow rates were determined from plant discharge data. At Lincoln, flow in
Salt Creek was determined from the Salt Creek at Lincoln, NE gauging station located
at 40 50 48N, 96 40 54W. The depth and width of the channel at Hastings were
measured at the time of deployment. The depth in Salt Creek was measured at the
time of deployment, and the width at the sampling point was estimated based on the
size of channel.
Decay rate coefficients (k) were determined by minimizing the root mean square error
(RMSE) of the model using the Solver function in Excel. The equation for the root mean
square error is defined in equation 5.

RMSE = [(y1 – y0)2 / n] 1/2

(5)

Where n is the number of points analyzed, y1 (ng/L) is the value of the measured
concentration, and y0 (ng/L) is value of the modeled concentration.
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Analytical Methods
Solvents and Internal Standards. Reference materials, metabolites and labeled
standards, including 13C3-caffeine and d9-methamphetamine, were obtained from
Sigma-Aldrich (St. Louis, MO). Phenyl-13C8-sulfamethazine was purchased from
Cambridge Isotopes (Andover, MA). Solvents used in sample preparation were high
purity grade (OPTIMA, Fisher Scientific, St. Louis, MO).
Extraction Methodology. Handling and elution of POCIS followed procedures described
previously (Alvarez 2004; Jones-Lepp et al. 2004). After the exposure period, each
individual POCIS device was removed from its deployment canister, briefly rinsed with
water if needed to remove debris and opened. The contents of the POCIS were
transferred using approximately 20 mL of high-purity methanol directly into silanetreated vials. Vials containing the methanol and sorbent were held at -20oC until they
could be processed for analysis.

Target compounds were eluted by passing 50 mL of high-purity methanol through
silane-treated glass gravity flow chromatography columns into 120 mL evaporation
tubes (RapidVAP, Labconco, Kansas City, MO). Approximately 1 ng of d9methamphetamine, 13C3-caffeine, and phenyl-13C8-sulfamethazine internal standards
were added to the eluate and used for quantification. Extracts were evaporated under
nitrogen to approximately 1 mL, and quantitatively transferred to autosampler vials for
analysis by liquid chromatography tandem mass spectrometry (LC/MS/MS). Standards
and spiking solutions were prepared from stock solutions (5 μg/μL) in methanol.
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Calibration solutions (2, 5, 12.5, 25 and 50 pg/μL) were prepared in 50:50 methanol and
water. All standards and extracts were stored in amber vials at -20˚C.

Liquid Chromatography-Tandem Mass Spectrometry. POCIS extracts were analyzed
for twenty-five pharmaceuticals and metabolites, as listed in Table 1. Standards and
extracts were analyzed on a Quattro Micro triple quadrupole with a Waters 2695 high
pressure liquid chromatography (HPLC) and autosampler. Electrospray ionization in
positive ion mode was used for detection of target compounds by multiple reaction
monitoring (MRM) with argon collision gas. A Thermo (Bellefonte, PA) Betabasic-18
column (250x2.1 mm, 5 um, 50°C) was used for separation at a flow rate of 0.2 ml/min
with a gradient of methanol with 0.1% formic acid in water. Mass spectrometer
operational parameters were optimized by infusing each compound separately (Table
2). The source conditions were: capillary 2.5 kV, extractor 2 V, RF lens 0.8 V, source
temp 90°C, desolvation temp 400°C, cone gas flow at 30 L/hr, and desolvation gas flow
at 700 L/hr. Compound retention times, ionization modes and MRM transitions are listed
in Table 2. A five point internal standard calibration curve was used for quantification of
each analyte. Methamphetamine-d3 was used as the internal standard for
methamphetamine and D(extro)-amphetamine, phenyl-13C8-sulfamethazine was used
for sulfa antibiotics and 13C3-caffeine was used as the internal standard for all other
target compounds. Based on the variability of the lowest standard (2 pg/μL), the
estimated detection limits for most compounds are less than 1 pg/μL, corresponding to
1 ng recovered from the POCIS. Recovery of target compounds was checked by
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analysis of fortified blanks spiked with known amounts of each compound and averaged
123 ± 30%. Two laboratory reagent blanks were processed with the POCIS samples,
with all compounds below instrument detection limits listed in Table 1. Additional
information on the analytical methods is included in Appendix C and further referenced
in Bartelt-Hunt et al. (2009).
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Chapter 4

Results

Results from Laboratory uptake experiments for 25 pharmaceuticals are presented in Figure 3 through 8. In each
figure, the average concentration observed in beakers containing POCIS samplers and the average concentration
observed in the positive controls (beakers with pharmaceuticals but no POCIS). The error bars represent the
standard error of the mean. Calculated uptake rates are presented in Table 3.
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Figure 3. Laboratory Uptake Data
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Figure 4. Laboratory Uptake Data
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Figure 5. Laboratory Uptake Data
45
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Figure 6. Laboratory Uptake Data
46
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Figure 7. Laboratory Uptake Data
47
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Figure 8. Laboratory Uptake Data
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Table 3. Calculated Rs values and comparisons to literature data.

Target Compounds

Experimental
Flowing, Rs
(Lday-1)

Standard
Error
(Unitless)

Reported
Flowing,
Rs (Lday1)

Source

1,7 dimethylxanthine
Caffeine
Acetaminophen

0.078
0.2
0.268

0.022
0.097
0.185

0.1

(Togola and Budzinski 2007)

Carbamazepine
d-Amphetamine
DEET
Diphenylhydramine

0.227
0.154
0.21
0.376
0.146
0.27
0.666
0.283
0.24
0.261
0.227
0.201
0.16
0.146
0.237
0.33
0.664
0.379
0.157
0.105
0.203
0.228

0.045
0.067
0.0043
0.066
0.039
0.05
0.158
0.07
0.063
0.05
0.06
0.075
0.056
0.113
0.091
0.074
0.041
0.029
0.058
0.054

0.31, 0.3

(MacLeod et al. 2007;
Togola and Budzinski 2007)

0.089

(Alvarez et al. 2007)

0.27

(Alvarez et al. 2007)

Erythromycin

Ibuprofen
Lincomycin
Methamphetamine
Monensin
Ractopamine
Sulfadimethoxine
Sulfamerazine
Sulfamethazole
Sulfamethoxazole
Sulfathiazole
Thiabendazole
Tiamulin
Tylosin
Azithromycin
Cotinine
Sulfachloropyridazine
Sulfamethazine
1

0.1

(MacLeod et al. 2007)
2

Values represent experimental data reported for 41 cm POCIS under flowing
conditions.
(-) indicated no standard error due to rapid uptake over one sampling period
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The data obtained from the field deployment is presented in Figures 9 through
18. In each plot, the average in-stream concentration for each of the two
sampling locations, Hastings, NE and Lincoln, NE is presented for each
pharmaceutical compound.
D-amphetamine, erythromycin, sulfachloropyridazine, sulfathiazole, tiamulin, and
tylosin were not detected in the field POCIS at either location.

Figure 9. Field Deployment Data
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Figure 10. Field Deployment Data
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Figure 11. Field Deployment Data
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Figure 12. Field Deployment Data
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Figure 13. Field Deployment Data
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Figure 14. Field Deployment Data
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Figure 15. Field Deployment Data
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Figure 16. Field Deployment Data
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Figure 17. Field Deployment Data
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Figure 18. Field Deployment Data
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Table 4. Calculated Decay Coefficients and RMSE values.
Hastings

Lincoln
Decay
Coefficient, k
(day-1)

Target Compounds

Decay Coefficient,
k (day-1)

RMSE

1,7 dimethylxanthine

0.260

1.757

0

1.169

Caffeine

0.773

4.607

0

1.249

Acetaminophen

53687091

0.701

19.8

0.261

Carbamazepine

0.695

7.731

2.63

1.437

d-Amphetamine

Not Determined

-

Not Determined

-

DEET

0.791

37.897

6.236

7.317

Diphenhydramine

0.027

6.043

3.211

1.143

Erythromycin

Not Determined

-

Not Determined

-

Ibuprofen

1.479

16.01

Not Determined

-

Lincomycin

0.072

0.827

31.2

0.12

Methamphetamine

0

0.906

1.052

0.099

Monensin

0.807

0.169

5.408

0.108

Ractopamine

0.222

0.398

0

0.191

Sulfadimethoxine

0.208

0.069

4.805

0.214

Sulfamerazine

2.407

0.034

9.175

0.0298

Sulfamethazole

0

0

9.175

0.0298

Sulfamethoxazole

0.051

1.68

5.11

5.46

Sulfathiazole

Not Determined

-

Not Determined

-

Thiabendazole

0.901

0.36

7.18

0.107

Tiamulin

Not Determined

-

Not Determined

-

Tylosin

Not Determined

-

Not Determined

-

Azithromycin

Not Determined

-

0

1.443

Cotinine

53687091

0

Not Determined

-

Sulfachloropyridazine

Not Determined

-

Not Determined

-

Sulfamethazine

0.867

0.778

11.41

0.045

RMSE
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Chapter 5
Discussion
Laboratory Uptake Experiments
The experimental Rs values determined for the pharmaceutical
compounds evaluated in this study are comparable to published uptake rates
under similar flowing conditions (Table 3). For example, previously-published Rs
values for carbamazepine were 0.31 and 0.3 L/day, respectively (MacLeod et al.
2007; Togola and Budzinski 2007). This compares well with the value for
carbamazepine of 0.227 L/day calculated in this study. Similarly, the
experimental Rs value determined for caffeine in this study is 0.2 L/day, which is
comparable to a value of 0.1 determined by Togola and Budzinski (2007).
Alvarez et al. (2007) reported an uptake rate for azithromycin of 0.27 L/day, while
the experimentally-determined uptake rate for azithromycin is 0.157 L/day.
MacLeod et al. (2007) reported an Rs value of 0.1 L/day for sulfamethazine, while
the current study calculated an uptake rate 0.228 L/day. Methamphetamine had
experimental Rs of 0.283 L/day, while Alvarez et al. (2007) reported an Rs of
0.089 L/day under comparable flowing conditions. In addition to these five
compounds with previously-published uptake rates, experimental uptake rates
were determined for 20 additional compounds with no previously reported values.
Lincomycin and tiamulin had the highest rates of uptake during the laboratory
study. Similar to other compounds analyzed, between days 0 and 3 there was
sharp decrease in contaminant concentration. This was originally assumed to be
extensive uptake, but was later determined to be dry POCIS saturation in water
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and evaporation. The negative control confirmed that contamination was limited
during the experiment. The raw data for this control and others is provided in
Appendix C. The positive controls also exhibited inconsistencies throughout the
30-day observation period. Often pharmaceutical concentration values exceeded
the initial spike amount at day 0. This was attributed to evaporation and/or
contamination during methods of recovery. A correction factor was utilized to
correct all pharmaceutical concentrations larger than initial sample concentration
taken at time 0.
During this study, all pharmaceuticals were analyzed at relatively low
concentrations, so some degree of analytical error may be present. Standard
error provided further validity to the data reported. The agreement between the
experimental uptake rates and those reported in other studies provides good
evidence that organic compound quantification using POCIS is reproducible, at
least over the range of environmental conditions employed in our study and
previously-published studies.

Field Deployment Data
Pharmaceuticals were detected receiving waters downstream of the
wastewater treatment plant outfall at both sampling locations. At Hastings 1,7dimethylxanthine, caffeine, carbamazepine, DEET, diphenylhydramine,
ibuprofen, lincomycin, methamphetamine, monensin, ractopamine,
sulfadimethoxine, sulfamerazine, sulfamethazine, sulfamethazole,
sulfamethoxazole, and thiabendazole were detected at every point downstream

63

from the WWTP. In Lincoln 1,7-dimethylxanthine, caffeine, carbamazepine, deet,
diphenylhydramine, lincomycin, methamphetamine, monensin, ractopamine, and
sulfadimethoxine sulfamerazine, sulfamethazine, sulfamethazole,
sulfamethoxazole, and thiabendazole were all detected in the field study. All
pharmaceuticals detected in the Lincoln WWTP effluent were also present in the
Hastings effluent with the exception of ibuprofen. It appears that antibiotics,
specifically the sulfa –based compounds, showed high levels of persistence in
wastewater effluents. DEET and carbamazepine had the highest average
effluent concentrations of 110 and 60 ng/L, respectively. Both also showed
persistence at both sites surveyed. At Lincoln, azithromycin originally showed
no occurrence in the wastewater effluent, but a spike of 2.2 ng/L appeared
approximately 1000m downstream effluent discharge point. This may be due to
desorption from sediment or additional runoff from surroundings non-point
sources. Although tiamulin was observed to undergo rapid uptake in the
laboratory uptake study, we observed persistence of this compound at both at
the Hastings and Lincoln locations. This may be due to enhanced persistence in
the natural environment due to association with aquatic sediment.
Some of the compounds appeared in the wastewater effluent, but
dissipated after discharge to the receiving water. At Hastings, acetaminophen,
cotinine, and sulfathiazole were degraded in-stream. At Lincoln, acetaminophen,
azithromycin, and sulfathiazole were degraded in stream. Acetaminophen and
cotinine are non-prescription drugs that appear to be easily eliminated at trace
levels. Sulfathiazole, a prescription antibiotic, showed substantial degradation
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over deployment period. This may be attributed to a smaller molecular weight
than other sulfa compounds studied. Compound stability may also be of
concern, as well.
Decay coefficients were determined from the collected field data as
described previously, and are presented in Table 4. Sulfamethazole was not
degraded at the Lincoln location in the study, therefore the decay coefficient and
RMSE (Table 4) for this compound was 0. Due to no effluent occurrence, decay
coefficients were not determined for sulfachloropyridazine, azithromycin, tylosin,
tiamulin, sulfathiazole, erythromycin, and d-amphetamine at Hastings. Decay
coefficients were not determined for sulfachloropyridazine, sulfathiazole, tylosin,
tiamulin, ibuprofen, erythromycin, and d-amphetamine at the Lincoln field site.
Acetaminophen and cotinine had very high decay coefficients, due to high initial
spikes and immediate dissipation. The very high dissipation rates made it
difficult to determine RMSE, due to only one non-zero data point. The opposite
was apparent for a few compounds in Lincoln with continuous occurrence.
Decay coefficients of 0 were calculated for 1,7-dimethylxanthine, caffeine, and
ractopamine at Lincoln. This was due to persistence along each POCIS
sampling site and minimal to no degradation. First-order decay models using the
calculated decay coefficients were fit to experimental data as presented in
Appendix A.
Various pharmaceutical compounds investigated in this study were
present in effluents and appeared to be resistant to WWTP removal and
degradation processes. Bartelt-Hunt et al. (2009) performed a field study at the
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same Nebraska sampling locations, with the exception of Columbus, Grand
Island, and Omaha, where similar compounds were analyzed. A laboratory
uptake experiment was not conducted, so Rs values were estimated using
Equation 2. Though estimations were used, various data exists in this study that
is comparable to previous work by published Bartelt-Hunt et al. (2009). The
experimental sampling rates for the sulfa-based drugs in this study were
approximately 0 to 0.5 units from values theoretically derived a few years prior.
Bartelt-Hunt et al. (2009) reported calculated flowing rates for
sulfachloropyridazine, sulfamethazine, sulfadimethoxine, sulfamethazole,
sulfamethoxazole, sulfamerazine, and sulfathiazole of 0.20, 0.18, 0.17, 0.21,
0.21, 0.20, and 0.22 L/day, respectively. In this study experimental flowing rates
of 0.203, 0.228, 0.227, 0.16, 0.146, 0.201, and 0.237 L/day were determined for
the same compounds, respectively. Acetaminophen, carbamazepine, DEET,
and methamphetamine were comparable as well with Rs values of 0.3 and 0.268,
0.20 and 0.227, 0.19 and 0.21, 0.22 and 0.283, L/day respectively. Both studies
failed to detect d-amphetamine and sulfathiazole at any point downstream from
either effluent discharge. Though previously detected, virginiamycin was not
analyzed in our current study.
In addition to sampling rates, Bartelt-Hunt et al. (2009) reported field
occurrence data that was comparable to data generated in this study.
Sulfamethoxazole had reported values downstream from the Lincoln and
Hastings effluent of 343 and 173 ng/L. This was approximately one order larger
than the mean concentration detected in this study of 35 ng/L. Ibuprofen
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displayed persistence at one location in this study, in contrast to the prior study.
A mean concentration of 60 ng/L was identified in the Hastings effluent. BarteltHunt et al. (2009) detected DEET concentrations of 181 and 1616 ng/L
downstream from Lincoln and Hastings, respectively. This study had DEET
Lincoln and Hastings concentration values of 55 and 155 ng/L, respectively.
Though the amount compound detected varied, a strong correlation is apparent
in the persistence and degradation of specific polar organic microcontaminants.
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Chapter 6
Conclusions and Future Directions
The objectives set forth in this study were accomplished. Uptake rates
were quantified for 25 pharmaceutical compounds by conducting a laboratory
uptake study, using POCIS. 20 additional uptake rates were calculated for
specified pharmaceuticals no previously documented values. Acetaminophen,
carbamazepine, methamphetamine, azithromycin, and sulfamethazine all
displayed uptake rates that compared to reported literature values. POCIS was
also used to evaluate the fate of polar organic contaminants in Nebraska surface
waters impacted by WWTP effluent. The field deployment data provided a
distinction between compounds that persist and those that degrade. We
concluded that select pharmaceuticals can persist for at least 1300 m
downstream. Batt et al. (2006) conducted a similar study but only at maximum
distance of 100m downstream from effluent. The first documented decay rates
were determined for 25 pharmaceuticals in receiving waters. Decay rates were
determined by minimizing RMSE and a combination of all loses which include:
biodegradation, hydrolysis, photolysis, and sorption.
The hypothesis that POCIS can evaluate occurrence and behavior of
pharmaceuticals in WWTP effluent was confirmed by data collected throughout
this study. This passive sampling technology performed efficiently at replicating
continuous exposure conditions, while be resistant to fouling. The data collected
here is reproducible and comparable to other studies conducted under similar
conditions and methods. Pharmaceutical loading rates, included in Appendix B,
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were calculated for each compound that displayed persistence using the average
in-stream concentration and volumetric flow rate. This gave a quantitative
description of daily microcontaminant mass discharged downstream
Future work may be conducted on both the laboratory uptake and field
deployment studies. Lincomycin and tiamulin had similar behavior under
controlled conditions, but differed in the natural environment. Lincomycin was
observed to persist in the field setting; however, it underwent rapid uptake in the
laboratory experiments. Tiamulin displayed rapid uptake in the laboratory, but
was not detected in the field study. Strategies to eliminate evaporation during
uptake study should also be explored. Evaporation played a large role in the
fluctuation of contaminant concentration during the laboratory uptake study.
There were frequent spikes where analyte concentration exceeded the original
spiked amount at time 0. Because the experiment was operated under controlled
conditions, it was concluded that evaporation was the reason for increase in
concentration. Though polar compounds have low volatility, measures should be
implemented to seal beakers. The sulfa-based compounds, DEET, and
carbamazepine showed the highest level of persistence, so their behavior and
potential effects on the environment should be further investigated.
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Appendix A
Model Fits for all 25 compounds analyzed at Hastings and Lincoln locations.
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Appendix B – Table of Loading Rates
Target Compounds

Hastings loading rates
(kg*day-1)

Lincoln loading rates
(kg*day-1)

1,7-dimethylxanthine

1.75E-04

1.44E-04

Caffeine

nd

nd

Acetaminophen

3.75E-04

4.40E-04

Carbamazepine

4.62E-04

5.81E-03

d-Amphetamine

nd

nd

DEET

2.24E-03

4.31E-03

Diphenhydramine

6.56E-05

1.17E-03

Erythromycin

nd

nd

Ibuprofen

7.08E-04

nd

Lincomycin

2.91E-05

8.99E-06

Methamphetamine

1.46E-05

8.09E-05

Monensin

1.02E-05

1.80E-05

Ractopamine

1.17E-05

2.70E-05

Sulfadimethoxine

5.83E-06

8.99E-05

Sulfamerazine

nd

nd

Sulfamethazole

1.46E-06

nd

Sulfamethoxazole

4.85E-04

2.29E-03

Sulfathiazole

nd

nd

Thiabendazole

7.29E-06

6.29E-05

Tiamulin

nd

nd

Tylosin

nd

nd

Azithromycin

nd

2.25E-04

Cotinine

nd

nd

Sulfachloropyridazine

nd

nd

Sulfamethazine

6.27E-05

8.99E-06

nd – not detected throughout field deployment period
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Appendix C – Analytical Methods QA/QC
Pharmaceutical Analysis of Water Samples
Extraction and analysis of pharmaceuticals in the aqueous samples was based
on previous methods (Snow et al. 2003; Batt et al. 2006) and modified to permit
the use of automated solid phase extraction (SPE) with detection by liquid
chromatography-tandem mass spectrometry. A Spark Holland Symbiosys
Environ (Spark Holland, Emmen, The Netherlands) on-line solid phase extraction
system was used with detection by electrospray ionization liquid chromatography
tandem mass spectrometry (LC/MS/MS. Up to twenty-five milliliter subsamples
water were weighed into 40-mL amber glass vials along with 10µL of reagent
grade formic acid. Each sample was spiked at 0.500 ng/mL (ppb) of
sulfamethazine-phenyl-13C6 (internal standard), 13C3 -caffeine and
demeclocyline (surrogate). Samples and standards were automatically extracted
using Prospekt 2/Symbiosis 2.0 x 10mm Oasis HLB solid phase extraction
cartridges and immediately eluted for LC/MS/MS analysis using a Quattro Micro
triple quadrupole mass spectrometer. A stepwise gradient separation was
performed using a Waters 2695 high pressure liquid chromatograph (HPLC). A
Thermo HyPurity C18 5um, 2x250mm column was used with a mobile phase
comprised of 97:3 water/methanol (A) and 3:97 methanol/water (B) each
containing 0.1% (v/v) formic acid. Elution and separation began with 95:5 A to B
for 2 min, changing to a linear gradient of 50:50 A to B to 25:75 A to B at 8
minutes, to 100% B for 18 minutes. Mobile phase composition was returned to
starting conditions until the end of the run.
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LC/MS/MS conditions and transitions were determined and optimized in positive
electrospray (ESI +) by infusing with concentrated standards and similar to those
shown in Table 1. A capillary voltage of 4.0 kV, an extractor of 3 V and an RF
lens of 0.1 V was used. The source temperature was 120°C and the desolvation
temperature was 500°C. The nebulizer flow rate was 700 L/hr in the desolvator
and 30 L/hr in the cone. Resolutions were set at 14 across the board and ion
energy 1 was 0.8 and ion energy 2 was 1.5. Instrument calibration was
performed using a five-point calibration curve over a concentration range from 10
to 1000 ng/L.

52
55
20
6
21
13
58
27
48
41
20
42
20
44
26
35
55
16
43
25

859
418
586
804
3
1
2
2
2
1
3
1
2
0
1
2
3
4
2
4
2
3
0
1
3

4

1289
1241
1388
1251
3
405
578
710
762
368
589
723
66
735
168
778
732
960
633
437
745
669
638
303
357
2 536
2 361
442
483

Tylosin

Tiamulin

Thiabendazole

Tetracycline

651
549
848
1414
2
1
2
2
3
1
3
2
3
1
0
3
2
4
3
1
2
2
3
1

Sulfathiazole

1999
1715
2027
2456
5
200
236
137
121
212
129
126
48
122
41
182
117
21
23
4
17
5
18
4
4
22

Sulfamethoxazole

Sulfamerazine

Sulfadimethoxine

Sulfachloropyridazine

293 16 3323 1045 2117
216 8 4832 819 1958
261 8 3282 1071 2125
268 13 2964 1514 1988
1
1
3 12
22
31
10
30
33
11
32
21
9
21
30
10
15
64
6
23
29
9
23
13
8
7
3
19
12
9
6
14
4
25
27
15
26
30
10
13
62
8
48
14
4
14
64
11
7
25
8
41
5
4
12
15
5
16
9
48
4
8
18
10
22
39
7
24

Sulfamethazole

2857 85
3629 113
2500 91
1725 28
1158 40
1924 94
1327 16
799
6
1376 34
427
6
2869 418
1227 37
100
84
2
30
7
38
5
6
59
2
9
10

511
881
1111
1068
3

Ractopamine

4818
4541
6348
7928

Oxytetracycline

Lincomycin

482
830
743
341

Monensin

Ibuprofen

1668
1522
3602
3414

Methamphetamine

Erythromycin

Diphenylhydramine

DEET

d-Amphetamine

2330 10 1284 494 896 2018
2301 6 1241 223 688 1116
2252 6 1197 557 957 2095
2408 13 1425 812 971 1830
1 1
3 10 10
1053
80
4694 290
1281
5992 299
913
5025 208
876
4034 674
484
2103 1199
914
4095 200
738
3579 104
157
845 204
794
3969 90
230
1071 151
1343
6373 164
912
3705 271
3572
3535 994
2574
2172 1093
833
504 209
2494
2015 900
1521
783 615
2816
2184 652
1868
1085 283
1673
902 514
2643
2068 945
1173
923 294
2981
2490 921
907
57 473

Sulfamethazine

98
148 43
204 26
197
109
182
200
18
203
19
138
166
26
29
15
20 27
18
16 44
14
12
9
18
26

833
724
669
783
6
746
1137
898
701
632
800
757
31
755
211
623
972
71
59
71
102
69
91
78
91
50
27 61
110 185
97

Cotinine

598
319
779
1031

Chlorotetracycline

257
375
332
345

Carbamazepine

94
237
165
143

Caffeine

Azithromycin

Sample_ID
PHARM1
PHARM2
PHARM3
PHARM4
N1
H-1-1
H-1-2
H-1-3
H-2-1
H-2-2
H-2-3
H-3-1
H-3-2
H-3-3
H-4-1
H-4-2
H-4-3
L-1-1
L-1-2
L-1-3
L-2-1
L-2-2
L-2-3
L-3-1
L-3-2
L-3-3
L-4-1
L-4-2
L-4-3

Acetaminophen

Lab_ID_String
09-863
09-864
09-865
09-866
09-867
09-1599
09-1600
09-1601
09-1602
09-1603
09-1604
09-1605
09-1606
09-1607
09-1608
09-1609
09-1610
09-1611
09-1612
09-1613
09-1614
09-1615
09-1616
09-1617
09-1618
09-1619
09-1620
09-1621
09-1622

1,7-Dimethylxanthine

90

Batch Analysis Date
2222 15 810 2124 1939 W09046
4/3/2009
1643 9 459 787 795 W09046
4/3/2009
1955 11 704 1519 1962 W09046
4/3/2009
1616 26 528 1948 2455 W09046
4/3/2009
2 2 2
4
1 W09046
4/3/2009
96 38
W09140
6/19/2009
114 62
W09140
6/19/2009
114 31
W09140
6/19/2009
65 26
W09140
6/19/2009
87 27
W09140
6/19/2009
82 122
W09140
6/19/2009
32 24
W09140
6/19/2009
11 5
W09140
6/19/2009
41 32
W09140
6/19/2009
7 7
W09140
6/19/2009
119 23
W09140
6/19/2009
50 25
W09140
6/19/2009
151 73
W09140
6/19/2009
141 68
W09140
6/19/2009
8 25
W09140
6/19/2009
54 59
W09140
6/19/2009
25 28
W09140
6/19/2009
57 35
W09140
6/19/2009
50 2
W09140
6/19/2009
15 16
W09140
6/19/2009
74 79
W09140
6/19/2009
7 11
W09140
6/19/2009
11 35
W09140
6/19/2009
9 31
W09140
6/19/2009

90

